Difficult Targets: Expanding Target Space (Room 206AB)

Sponsored By 

Session Chair - Funded(s)

• 

  Amine Sadok, PhD

  Amgen, California, United States

Presentations:

• 10:00 AM – 10:30 AM EST

  Integrating Artificial Intelligence and Traditional Screens for Targeting “Undruggable" Cancer Targets
  

  Igor Stagljar, PhD – University of Toronto School of Medicine
• 10:30 AM – 11:00 AM EST

  RAPID – photoaffinity-based high-throughput ligand discovery in cells
  

  Matt Labenski, PhD (he/him/his) – Jnana Therapeutics
• 11:00 AM – 11:30 AM EST

  Targeting ubiquitin protease system to treat MYC-driven breast cancer
  

  Sudhakar Jha, PhD (he/him/his) – Oklahoma State University, College of Veterinary Medicine, Stillwater, OK, USA
• 11:30 AM – 12:00 PM EST

  Sorafenib and Lenvatinib induce vascular responses in patient derived HCC on-Chip models
  

  Bas Trietsch – PhD